ExcoInTouch to showcase patient engagement solutions at J&J
digital health masterclass
30 October 2013
Nottingham-based ExcoInTouch, a developer of patient engagement
and data-capture systems, has announced it is taking part in a
Johnson & Johnson Digital Health Masterclass to demonstrate the
benefits of mHealth.
The program, comprising three digital health-focused interactive
workshops, each of which runs for three days, during September to
November 2013. The event will culminate in an Investor Day and
Digital Health Challenge, being staged in association with the
Health 2.0 Europe conference.
“The last fifty years were about the science of medicine: new
drugs, new therapies, and new technology. The next fifty years will
see a focus on the science of healthcare delivery: how we improve
the way care is delivered. This shift represents a massive change
for pharmaceutical companies. It also changes the way we need to
think about technology”, commented Professor Zack Cooper of Yale
University and the London School of Economics.
Every year, the pharmaceutical industry loses an estimated $564
billion due to patients failing to take their drugs properly.
Consequently, increasing adherence through highly efficient,
simple-to-use patient engagement solutions will have a huge impact
on the cost and effectiveness of healthcare delivery.
Exco InTouch will leverage their expertise, spanning from almost
ten years’ experience in patient engagement and clinical data
capture to showcase to industry peers and executives, the benefits
that device independent, intelligent and adaptive solutions provide,
in terms of increasing medication adherence and treatment management
within both clinical and commercial environments.
Tim Davis, CEO and co-founder of Exco InTouch commented: “The
Johnson & Johnson Digital Health Masterclass provides Exco InTouch
with the opportunity to share our experiences, whilst learning from
the contributions of other companies operating in the clinical and
healthcare markets. We aim to inform the market on the scale of the
healthcare challenge and the extent to which mHealth can offer
highly reliable and effective solutions, both now and for the
"Indeed, in the UK alone, non-adherence by patients is already
costing the NHS £500 million every year, but by engaging the market
in mHealth, we are developing fully integrated, intelligent programs
that increase patient adherence and facilitate improved condition
management for patients, meeting the needs of healthcare providers
and the pharmaceutical industry as it continues to grow, change and
remould itself at a rapid pace.
“Best practice in the performance and implementation of mHealth
programs inevitably has a highly positive impact on patient care and